What is the current market size and future outlook for the self-expanding stents market?
The self-expanding stents market size has grown strongly in recent years. It will grow from $3.31 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increased awareness, growth in aging population, expansion of indications for stent usage beyond coronary arteries, growth in disposable income levels, and increased adoption of minimally invasive procedures.
The self-expanding stents market size is expected to see strong growth in the next few years. It will grow to $4.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular diseases, expansion of healthcare infrastructure, expansion of telemedicine services for remote consultation, growing incidence of peripheral arterial disease, and increase in the prevalence of chronic diseases. Major trends in the forecast period include technological advancements, bioresorbable stents, drug-eluting stents, minimally invasive procedures, and integration of artificial intelligence.
Get Your Free Sample of The Global Self-Expanding Stents Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15667&type=smp
How has the self-expanding stents market evolved, and what factors have shaped its growth?
The growing prevalence of cardiovascular diseases is expected to propel the growth of the self-expanding stents market going forward. Cardiovascular illnesses are abnormalities of the heart and blood vessels. The growing cases of cardiovascular diseases is due to obesity, an aging population, and genetic predispositions. Self-expanding stents are useful in the therapy of cardiovascular disorders, as it provides effective and minimally invasive therapeutic alternatives for both urgent and long-term patient demands. For instance, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the self-expanding stents market.
What are the major segments of the self-expanding stents market?
The self-expanding stents market covered in this report is segmented –
1) By Product Type: Gastrointestinal Self-Expanding Stents, Carotid Self-Expanding Stents, Endovascular Self-Expandable Stents, Other Product Types
2) By Applications: Fem-Pop Artery Stents, Iliac Artery Stents, Carotid Artery Stents, Biliary Stents, Other Applications
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Gastrointestinal Self-Expanding Stents: Esophageal Stents, Duodenal Stents, Colonic Stents
2) By Carotid Self-Expanding Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents
3) By Endovascular Self-Expandable Stents: Aortic Stents, Renal Artery Stents, Peripheral Artery Stents
4) By Other Product Types: Biliary Self-Expanding Stents, Urological Self-Expanding Stents
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report
Which companies dominate the self-expanding stents market?
Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE & Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH
How will evolving trends contribute to the growth of the self-expanding stents market?
Major companies operating in the self-expanding stents market are focusing their efforts on introducing solutions, such as tracheal stent system, to reduce the need for open surgery and gain a competitive edge in the market. A tracheal stent system is a medical device used to support and maintain the patency of the trachea, often employed in cases of tracheal stenosis or collapse. For instance, in February 2022, Micro-Tech Endoscopy Inc., a US-based medical technology company, launched a tracheobronchial nitinol y-stent. It is a flexible, self-expanding stent composed of a nitinol alloy with a low-profile delivery mechanism, a silicone coating to prevent tumor ingrowth, and repositionable sutures for adjustment or removal. For individuals suffering from tracheobronchial strictures, this stent relieves symptoms by expanding the airway and enhancing airflow.
What are the key regional dynamics of the self-expanding stents market, and which region leads in market share?
North America was the largest region in the self-expanding stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Self-Expanding Stents Market Report 2025 Offer?
The self-expanding stents market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Self-expanding stents are medical devices designed to open and maintain the patency (openness) of narrowed or blocked blood vessels or tubular structures within the body. These stents are made of flexible materials, often metal alloys such as nitinol, which have the property of self-expansion when deployed in the body. The purpose of self-expanding stents is to treat various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15667
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
